What Pathology Watch does

PathologyWatch is a US-based digital dermatopathology company that provides dermatologists and hospital dermatology departments with an end-to-end workflow for biopsy processing, whole-slide digital imaging, expert dermatopathologist interpretation, and EMR-integrated reporting. Its core technology platform, DOT. (Dermpath Optimization Technology), converts glass slides into interactive digital images viewable 24/7 and integrates with any EMR/EHR system via Health Level 7 (HL7) interfaces, enabling direct ordering, results delivery, and clinician-to-pathologist collaboration through a HIPAA-compliant, SSL-encrypted provider portal. The company also operates a patient-facing results access layer (SonicMyAccess) post-Sonic-acquisition.

The business operates a hybrid lab-services and software-as-a-service model. PathologyWatch generates revenue primarily through contracted dermatopathology laboratory services billed to healthcare providers and insurance payers, with subscription-like recurring revenue from EMR interface and connectivity services. Go-to-market combines direct enterprise field sales to dermatology practices and hospital systems with a self-serve provider portal for mid-market clinics, supplemented by clinician education programs, webinars, and thought-leadership content such as the Digital Dermatopathology Digest video series. The company claims operational outcomes of approximately 30% workflow efficiency improvement, 75% faster turnaround, and a 48-hour routine case turnaround versus fax-based industry baselines (noting that 65% of dermatologists still receive pathology reports via fax).

PathologyWatch was founded in 2017, is headquartered in Murray, Utah, and employs 101-250 people. It raised approximately $5 million in Series A funding in May 2020 and $25 million in Series B funding in November 2021, and was acquired by Sonic Healthcare for $130 million in an agreement announced November 2021 with closing expected in December 2023. PathologyWatch now operates as part of Sonic Healthcare USA's Dermatopathology Division, with planned laboratory expansion into Texas, Florida, and Arizona and stated R&D investment in AI-based skin cancer detection.

Name

Pathology Watch

Legal name

PathologyWatch

Website

https://pathologywatch.com

Company type

Private

Founded year

2017

Operating status

Acquired

Headcount range

101–250 employees

Short description

PathologyWatch is a US digital dermatopathology platform that converts biopsies into whole-slide digital images, integrates with EMRs via HL7, and delivers dermatopathology diagnoses to dermatology practices and hospitals with 48-hour turnaround times.

Ownership category

akta.pro rank

Product category

Digital Dermatopathology Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB)

akta.pro secondary industries

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Dermatopathology (HLAKACAC), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ), Dermatology Telemedicine Platforms (HLALAGAA)

Keywords

• Digital dermatopathology
• Pathology laboratory services
• Dermatology diagnostics
• Whole-slide imaging
• EMR integration services

Headquarters

HQ city

Murray

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Digital Dermatopathology Laboratory Services: Laboratory services for dermatopathology including biopsy processing, slide preparation, digital imaging, and diagnostic reporting. Revenue generated through pathology testing services billed to healthcare providers, insurance payers, and patients. Services include 48-hour turnaround for routine cases and 24/7 access to digital slides and reports.
2. EMR Integration and Connectivity Solutions: Digital integration services enabling EMR/EHR connectivity using HL7 standards. Provides interface setup and maintenance for clinics to integrate PathologyWatch services into their practice workflow.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

PathologyWatch operates a digital dermatopathology laboratory service that processes skin biopsy specimens into whole-slide digital images and delivers diagnostic reports to dermatologists through its proprietary DOT. (Dermpath Optimization Technology) platform. The service combines physical laboratory operations with a cloud-based digital platform that provides 24/7 slide access, HL7-based EMR/EHR integration, and access to a national network of board-certified dermatopathologists.

Product overview

PathologyWatch operates as a digital dermatopathology platform offering a unified suite of digital pathology solutions. The core platform is PathologyWatch, supported by DOT. (Dermpath Optimization Technology), which serves as the primary digital interface for case management, digital slide viewing, and pathologist collaboration. The service portfolio includes Digital Dermatopathology (end-to-end slide digitization), a Provider Portal for web-based ordering and results, an EMR/EHR Interface service using HL7 integration, and Patient Access Solutions (SonicMyAccess) for patient result viewing. These products work together to deliver a complete digital workflow from biopsy to diagnosis.

Differentiator

Problem solved

Functional benefit

Brands

• DOT. Dermpath Optimization Technology - a digital pathology platform and dermpath virtual assistant that enables clinicians to manage case workload, view digital images and case files, create detailed pathology reports, and collaborate with colleagues.

Products and services

• PathologyWatch Digital Dermatopathology Platform Leading digital dermatopathology platform providing digital pathology solutions for dermatology practices. Helps manage workflows, enhance collaboration with dermatopathologists, and optimize patient outcomes through next-generation digital solutions.
• DOT. (Dermpath Optimization Technology)

Quantifiable outcome

• 30% more efficient workflow for partner clinics
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability1 record

Feature4 records

Partnerships

One partnership is on record.

• The Solution LabminorStrategic or Co-development PartnerPartnership with The Solution Lab to conduct a nationwide survey of dermatologists to identify dermatopathology pain points and challenges. Results were published and used to inform product development and marketing messaging.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• DermTech: DermTech operates in dermatology diagnostics with a non-invasive genomic skin assessment platform. Comparable to PathologyWatch because both target dermatologists with diagnostic content beyond traditional histopathology and compete for dermatology practice mindshare and biopsy-related revenue.
• NeoGenomics: NeoGenomics is a national oncology and anatomic pathology laboratory serving hospitals, dermatologists, and oncology practices. Directly comparable as a competing dermatopathology lab with digital reporting capabilities and similar reference-lab economics.
• Aurora Diagnostics: Aurora Diagnostics operates a network of anatomic pathology practices including dermatopathology labs serving community dermatologists. Comparable as a multi-site dermatopathology reference lab with digital reporting and similar reference-lab economics.

Broad incumbents

• Sonic Healthcare USA (Dermatopathology Division): Sonic Healthcare USA is PathologyWatch's parent and operates a large, multi-specialty anatomic pathology network including dermatopathology. Comparable as both a parent and a peer: it supplies PathologyWatch with infrastructure while also offering competing lab services in adjacent specialties.
• Akoya Biosciences: Akoya provides spatial biology and digital pathology platforms used by research and clinical labs. Comparable as a digital pathology infrastructure provider that could underpin or compete with PathologyWatch's whole-slide imaging and analysis workflow.
• Quest Diagnostics: Quest Diagnostics is one of the largest U.S. clinical reference laboratories, offering dermatopathology and broad anatomic pathology services. Comparable as a large incumbent competing for the same dermatology practice lab contracts with national scale.
• Labcorp: Labcorp operates a national clinical and anatomic pathology lab network including dermatopathology services. Comparable as a dominant incumbent with the scale, payer relationships, and IT integrations that PathologyWatch must displace to win enterprise dermatology contracts.

Emerging players

• Proscia: Proscia is a digital pathology software vendor offering AI-enabled workflow and image management for pathology labs. Comparable as a software-and-AI competitor for pathology workflow digitization, though it focuses on broader anatomic pathology rather than dermatopathology specifically.
• PathAI: PathAI develops AI-powered pathology diagnostics and collaborates with labs and biopharma. Comparable as a technology-forward competitor building AI interpretation layers on top of digitized slides, the same trajectory PathologyWatch is pursuing.
• Ibex Medical Analytics: Ibex builds AI-based cancer diagnostics for pathology, including dermatopathology applications. Directly comparable as an AI-first pathology vendor targeting the same workflow and diagnostic accuracy gains PathologyWatch seeks to deliver.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sonic-healthcare-usa/?viewAsMember=true
• Xx.com/watchpathology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds8 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pathology Watch